Target intelligence / Profile preview

Cellular immune system via cell-cell contact and secretome

Molecular classification
Biological System, Cellular Signaling Network, Immune Pathway
01

Overview

The cellular immune system operates through a combination of direct cell-cell contact and the release of a complex secretome to coordinate host defense and maintain tissue homeostasis (NCBI, NBK279364). Cell-cell contact is mediated by specialized surface molecules, such as the interaction between the T-cell receptor (TCR) and the major histocompatibility complex (MHC), which is essential for antigen recognition and immune activation (PubMed, PMC3135642). Simultaneously, the secretome—comprising cytokines, chemokines, and extracellular vesicles—acts as a paracrine and endocrine signaling network to recruit and polarize immune cells (Nature Reviews Immunology, 2017). Dysregulation of these processes is central to the pathogenesis of various conditions, including cancer, where tumors evade immune detection, and autoimmune diseases, where the system attacks self-tissues (StatPearls, NBK459471). Therapeutic intervention often involves monoclonal antibodies that block inhibitory checkpoints or recombinant cytokines that stimulate immune effector functions (NIH, 2023). Because this term encompasses an entire physiological system and multiple signaling modalities, it does not represent a single druggable molecular target but rather a broad biological framework.

Other names
Cell-mediated immunityImmune system signalingIntercellular immune communicationImmune synapse and paracrine signaling
02

Mechanism of action

Modulation of immune cell communication through the agonism or antagonism of cell-surface receptors and the neutralization or supplementation of secreted signaling proteins (PubMed, PMC7151665).

03

Biological functions

Antigen presentationCytokine signalingLeukocyte traffickingCell-mediated cytotoxicityImmune homeostasisSignal transduction
04

Disease associations

CancerAutoimmune diseaseInfectionChronic inflammationImmunodeficiency
05

Safety considerations

Cytokine release syndrome (CRS)Immune-related adverse events (irAEs)Increased susceptibility to opportunistic infectionsSystemic inflammatory response syndrome (SIRS)
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

Circulating cytokine levels (e.g., IL-6, TNF-alpha)Immune cell phenotyping via flow cytometryExpression levels of ligand-receptor pairs (e.g., PD-1/PD-L1)C-reactive protein (CRP)

Beyond the preview

Go deeper on Cellular immune system via cell-cell contact and secretome.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular immune system via cell-cell contact and secretome.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call